Shota Yoshida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shota Yoshida has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Akinori Miyakoshi
Department of Neurosurgery, Shizuoka General Hospital, Shizuoka, Japan
2 shared publications - Daisuke Arai
Pulmonary Division, Department of Internal Medicine, Saiseikai Utsunomiya Hospital, Tochigi, Japan
2 shared publications - Masahiro Onozawa
Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
2 shared publications - Takanori Teshima
Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
2 shared publications Tsukasa Sato
Department of Neurosurgery, Shizuoka General Hospital, Shizuoka, Shizuoka, Japan
2 shared publications- Yoshifumi Kawanabe
Department of Neurosurgery, Shizuoka General Hospital, Shizuoka, Shizuoka, Japan
2 shared publications
Latest Publications
- 7 September 2026
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 65 (9) , e70171
Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia
The KAT6A::NCOA2 (formerly MOZ::TIF2 ) fusion is an extremely rare recurrent genetic abnormality in acute myeloid leukemia (AML), with only nine cases reported to date. It has consistently been associated with inv(8)(p11q13). However, the genomic mechanism underlying this fusion has remained unresolved. Because both KAT6A and NCOA2 are transcribed in the same reverse orientation on chromosome 8, a simple inversion is structurally insufficient to generate a transcriptionally competent fusion transcript, creating a long‐standing cytogenetic paradox. We analyzed an AML case harboring a KAT6A::NCOA2 fusion using targeted genomic profiling and breakpoint‐level validation. In addition to the canonical KAT6A::NCOA2 fusion, sequencing identified an unexpected MTFR1::KAT6A rearrangement. Since MTFR1 is located between KAT6A and NCOA2 on chromosome 8, we hypothesized a complex intrachromosomal rearrangement. Genomic breakpoint analysis revealed that the fusion was generated not by a single inv(8), but by two adjacent intrachromosomal inversions forming a tandem double inversion. This rearrangement reoriented genomic segments to place KAT6A and NCOA2 in a transcriptionally compatible configuration, enabling fusion formation. These findings resolve the structural paradox of KAT6A::NCOA2 ‐positive AML by demonstrating that a cytogenetically apparent inv(8)(p11q13) can conceal a tandem double‐inversion architecture that reorients KAT6A and NCOA2 into a transcriptionally compatible configuration.
- 7 September 2026
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 65 (9) , e70171
Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia
The KAT6A::NCOA2 (formerly MOZ::TIF2 ) fusion is an extremely rare recurrent genetic abnormality in acute myeloid leukemia (AML), with only nine cases reported to date. It has consistently been associated with inv(8)(p11q13). However, the genomic mechanism underlying this fusion has remained unresolved. Because both KAT6A and NCOA2 are transcribed in the same reverse orientation on chromosome 8, a simple inversion is structurally insufficient to generate a transcriptionally competent fusion transcript, creating a long‐standing cytogenetic paradox. We analyzed an AML case harboring a KAT6A::NCOA2 fusion using targeted genomic profiling and breakpoint‐level validation. In addition to the canonical KAT6A::NCOA2 fusion, sequencing identified an unexpected MTFR1::KAT6A rearrangement. Since MTFR1 is located between KAT6A and NCOA2 on chromosome 8, we hypothesized a complex intrachromosomal rearrangement. Genomic breakpoint analysis revealed that the fusion was generated not by a single inv(8), but by two adjacent intrachromosomal inversions forming a tandem double inversion. This rearrangement reoriented genomic segments to place KAT6A and NCOA2 in a transcriptionally compatible configuration, enabling fusion formation. These findings resolve the structural paradox of KAT6A::NCOA2 ‐positive AML by demonstrating that a cytogenetically apparent inv(8)(p11q13) can conceal a tandem double‐inversion architecture that reorients KAT6A and NCOA2 into a transcriptionally compatible configuration.
- 31 May 2025
- Published by Elsevier in Experimental Hematology
- Vol. 149, 104819
Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks
- 31 May 2025
- Published by Elsevier in Experimental Hematology
- Vol. 149, 104819
Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks
- Open Access
- 1 January 2022
- Published by The Japanese Society for Neuroendovascular Therapy in Journal of Neuroendovascular Therapy
- Vol. 16 (4) , 204-210
A Case of an Early Pregnant Woman with Congenital Protein S Deficiency Who Underwent Mechanical Thrombectomy
Objective: Large vessel occlusion (LVO) stroke during pregnancy is rare but a life-threatening issue for the mother and fetus. We report a rare case of a pregnant woman with congenital protein S deficiency who underwent mechanical thrombectomy. Case Presentation: A 35-year-old woman presented with right hemiplegia and aphasia. The National Institutes of Health Stroke Scale was 23 and MRI revealed acute infarction on the left hemisphere. MRA showed disruption of the left middle cerebral artery. Mechanical thrombectomy was performed following intravenous thrombolysis, and then complete recanalization was achieved. The reduction in protein S activity due to pregnancy was suspected to have affected LVO. Subsequently, the patient was diagnosed with congenital protein S deficiency and recovered to modified Rankin scale 2 at 3 months after the onset. Conclusion: Aggravation of congenital protein S deficiency due to pregnancy led to the onset of LVO. The patient showed a good outcome after mechanical thrombectomy.
- 1 January 2022
- Published by The Japanese Society for Neuroendovascular Therapy in Journal of Neuroendovascular Therapy
- Vol. 16 (4) , 204-210
Open AccessA Case of an Early Pregnant Woman with Congenital Protein S Deficiency Who Underwent Mechanical Thrombectomy
Objective: Large vessel occlusion (LVO) stroke during pregnancy is rare but a life-threatening issue for the mother and fetus. We report a rare case of a pregnant woman with congenital protein S deficiency who underwent mechanical thrombectomy. Case Presentation: A 35-year-old woman presented with right hemiplegia and aphasia. The National Institutes of Health Stroke Scale was 23 and MRI revealed acute infarction on the left hemisphere. MRA showed disruption of the left middle cerebral artery. Mechanical thrombectomy was performed following intravenous thrombolysis, and then complete recanalization was achieved. The reduction in protein S activity due to pregnancy was suspected to have affected LVO. Subsequently, the patient was diagnosed with congenital protein S deficiency and recovered to modified Rankin scale 2 at 3 months after the onset. Conclusion: Aggravation of congenital protein S deficiency due to pregnancy led to the onset of LVO. The patient showed a good outcome after mechanical thrombectomy.
- Open Access
- 1 January 2021
- Published by Japanese Society of Spinal Surgery in Spinal Surgery
- Vol. 35 (1) , 103-105
Simultaneous Microscopic Posterior Herniotomy and Cervical Laminoplasty for Cervical Postero-lateral Disc Herniation with Cervical Canal Stenosis
- 1 January 2021
- Published by Japanese Society of Spinal Surgery in Spinal Surgery
- Vol. 35 (1) , 103-105
Open AccessSimultaneous Microscopic Posterior Herniotomy and Cervical Laminoplasty for Cervical Postero-lateral Disc Herniation with Cervical Canal Stenosis